Jacqueline E. Shea - 26 Feb 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Executive Officer, Director
Signature: /s/ Jacqueline E. Shea
Issuer symbol: INO
Transactions as of: 26 Feb 2025
Net transactions value: -$22,930
Form type: 4
Filing time: 28 Feb 2025, 18:05:39 UTC
Previous filing: 16 May 2024
Next filing: 12 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+5,852	+17%		39,499	26 Feb 2025	Direct	F1
transaction	INO	Common Stock	Tax liability	$4,936	-2,493	-6.3%	$1.98	37,006	26 Feb 2025	Direct	F2
transaction	INO	Common Stock	Options Exercise		+18,632	+50%		55,638	26 Feb 2025	Direct	F3
transaction	INO	Common Stock	Tax liability	$17,994	-9,088	-16%	$1.98	46,550	26 Feb 2025	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-5,852	-100%	$0.000000	0	26 Feb 2025	Common Stock	5,852		Direct	F1
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-18,632	-33%	$0.000000	37,263	26 Feb 2025	Common Stock	18,632		Direct	F3
transaction	INO	Common Stock Option	Award	$0	+105,649		$0.000000	105,649	27 Feb 2025	Common Stock	105,649	$1.94	Direct	F5
transaction	INO	Restricted Stock Unit	Award	$0	+85,201		$0.000000	85,201	27 Feb 2025	Common Stock	85,201		Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 17,557 restricted stock units granted on February 26, 2022 was as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
F3	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 is as follows: 18,632 shares vested on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein.
F5	The vesting schedule for the 105,649 options is as follows: 52,825 shares vested on February 27, 2025 and 52,824 shares will vest on February 26, 2026.
F6	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 is as follows: 28,401 shares will vest on February 26, 2026; 28,400 shares will vest on February 26, 2027; and 28,400 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.